Skip to content

Cellanome

Live-cell imaging linked to single-cell gene expression

Raised to date

$75.9M

of $75.9M offered across 1 Form D filing

Investors
22
Last filed
Jun 22, 2026

About

Cellanome is a Foster City, California life-science tools company building a multimodal single-cell analysis platform. Its technology pairs time-lapse live-cell imaging with single-cell molecular profiling such as transcriptomics, so researchers can watch cells behave over time and then connect that behavior to their molecular state. The company was founded by veterans of Illumina and Seer, with Omead Ostadan as CEO, Mostafa Ronaghi as cofounder and Jay Flatley as chairman. It sells into oncology, immunology, neuroscience, and aging and metabolic disease research.

Proprietary CellCage micro-environments keep individual cells or small ensembles in a biocompatible enclosure through culture, imaging, perturbation and sequencing, so dynamic behavior and downstream molecular readouts come from the same cells in one integrated workflow rather than from separate static assays.

Funding

  • EquityFiled Jun 22, 2026Form D
    $75.9M/ $75.9M

Product

R3200 Platform

Life science research instrument

A fully integrated system combining instrumentation, consumables and software that runs complex single-cell assays end to end, capturing fluorescent live-cell imaging and transcriptomic readouts from cells held in CellCage enclosures.

  • CellCage biocompatible micro-environments that preserve native cell morphology
  • Fluorescent live-cell time-lapse imaging paired with single-cell transcriptomics
  • Integrated instrument, consumables and software in one workflow

Built for

Academic and commercial life-science researchers in oncology, immunology, neurobiology and aging research, including pharmaceutical and biotech R&D groups

People on file